The impact of the COVID-19 pandemic on the quality of life of head and neck cancer survivors.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 18 12 2020
accepted: 01 04 2021
pubmed: 17 4 2021
medline: 16 10 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Head and neck cancer (HNC) survivors are particularly vulnerable to the deleterious consequences of lockdown and social distancing. The psychosocial effects of the COVID-19 pandemic on this group are still unknown, and we want to explore how their quality of life (QoL) has changed in this unique situation. An online survey, composed of pandemic-specific items, plus the EORTC QLQ-C30, was administered to a cohort of HNC survivors. Using previously published reference values as a control group, we have evaluated the impact of the pandemic on their QoL. We have also explored the differences between those who had received a total laryngectomy (LP, laryngectomized population) vs other HNC patients, in order to assess the role of tracheostomy in this regard. One hundred and twenty-one HNC patients completed the survey. The scores of the physical (80.5 vs 85, p = 0.028), role (78 vs 84, p = 0.030), and emotional functioning (76 vs 81, p = 0.041) were significantly different in the two groups, with worse functioning in our patients. Comparing LP with the other HNC patients, social (76.6 vs 88.9, p = 0.008) and physical functioning (75.5 vs 86.1, p = 0.006) were significantly worse in the former group. LP also reported a greater perception that others are afraid to be close to them (1.67 vs 1.32, p = 0.020). No differences were found between LP with and without voice prosthesis. Our results show how HNC patients are at high risk for a worsening in QoL because of the ongoing COVID-19 global pandemic.

Sections du résumé

BACKGROUND BACKGROUND
Head and neck cancer (HNC) survivors are particularly vulnerable to the deleterious consequences of lockdown and social distancing. The psychosocial effects of the COVID-19 pandemic on this group are still unknown, and we want to explore how their quality of life (QoL) has changed in this unique situation.
MATERIALS AND METHODS METHODS
An online survey, composed of pandemic-specific items, plus the EORTC QLQ-C30, was administered to a cohort of HNC survivors. Using previously published reference values as a control group, we have evaluated the impact of the pandemic on their QoL. We have also explored the differences between those who had received a total laryngectomy (LP, laryngectomized population) vs other HNC patients, in order to assess the role of tracheostomy in this regard.
RESULTS RESULTS
One hundred and twenty-one HNC patients completed the survey. The scores of the physical (80.5 vs 85, p = 0.028), role (78 vs 84, p = 0.030), and emotional functioning (76 vs 81, p = 0.041) were significantly different in the two groups, with worse functioning in our patients. Comparing LP with the other HNC patients, social (76.6 vs 88.9, p = 0.008) and physical functioning (75.5 vs 86.1, p = 0.006) were significantly worse in the former group. LP also reported a greater perception that others are afraid to be close to them (1.67 vs 1.32, p = 0.020). No differences were found between LP with and without voice prosthesis.
CONCLUSIONS CONCLUSIONS
Our results show how HNC patients are at high risk for a worsening in QoL because of the ongoing COVID-19 global pandemic.

Identifiants

pubmed: 33860361
doi: 10.1007/s00520-021-06198-6
pii: 10.1007/s00520-021-06198-6
pmc: PMC8049620
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6297-6304

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. The Author(s).

Références

Sci Total Environ. 2020 Oct 1;737:139806
pubmed: 32492608
Transl Psychiatry. 2020 Jul 31;10(1):263
pubmed: 32737292
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32631833
Am J Obstet Gynecol. 2020 Nov;223(5):725.e1-725.e9
pubmed: 32598911
Cancer. 2018 Oct 15;124(20):4072-4079
pubmed: 30335190
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Oral Oncol. 2015 Oct;51(10):888-900
pubmed: 26209066
PLoS One. 2012;7(4):e35797
pubmed: 22563403
Eur J Cancer. 2001 Jul;37(11):1331-4
pubmed: 11435060
Eur Arch Otorhinolaryngol. 2006 Jan;263(1):1-8
pubmed: 16001247
Psychooncology. 2002 May-Jun;11(3):249-56
pubmed: 12112486
Clin Genitourin Cancer. 2021 Apr;19(2):e63-e68
pubmed: 32863188
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Radiother Oncol. 2020 Jun;147:84-85
pubmed: 32247204
Cancer. 2020 Oct 1;126(19):4414-4422
pubmed: 32697342
Heliyon. 2020 Jun 24;6(6):e04315
pubmed: 32613133
Head Neck. 2020 Jun;42(6):1209-1213
pubmed: 32298035
JMIR Aging. 2020 May 7;3(1):e19007
pubmed: 32356777
Front Oncol. 2020 Jun 23;10:1128
pubmed: 32714873
Int J Environ Res Public Health. 2020 Sep 21;17(18):
pubmed: 32967091
Otolaryngol Head Neck Surg. 2020 Jul;163(1):81-82
pubmed: 32340542
Psychooncology. 2020 Sep;29(9):1377-1379
pubmed: 32779778
JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):284-8
pubmed: 26796781
Eur J Cancer. 2020 Sep;136:132-139
pubmed: 32683273
Cancers (Basel). 2020 Aug 14;12(8):
pubmed: 32823999
Eur J Cancer. 2000 Sep;36(14):1796-807
pubmed: 10974628
Head Neck. 2020 Jun;42(6):1150-1152
pubmed: 32338797
JNCI Cancer Spectr. 2020 Nov 05;5(1):pkaa104
pubmed: 33437925
Otolaryngol Head Neck Surg. 2020 Jul;163(1):67-69
pubmed: 32340538
Head Neck. 2020 Nov;42(11):3141-3152
pubmed: 32627261
J Infect. 2020 Aug;81(2):e156-e158
pubmed: 32534002
J Allergy Clin Immunol. 2020 Sep;146(3):542-544
pubmed: 32605856
J Med Internet Res. 2020 Jul 10;22(7):e20001
pubmed: 32614778
Otolaryngol Head Neck Surg. 2021 Feb;164(2):277-284
pubmed: 32746738
Oral Oncol. 2020 Aug;107:104841
pubmed: 32527570
Front Oncol. 2020 Jul 10;10:1270
pubmed: 32754447
Int J Surg. 2018 Oct;58:65-70
pubmed: 30261330
Ann Oncol. 2020 Aug;31(8):1088-1089
pubmed: 32330541

Auteurs

Oreste Gallo (O)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy. oreste.gallo@unifi.it.

Chiara Bruno (C)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Luca Giovanni Locatello (LG)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Federica Martelli (F)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Maria Cilona (M)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Pietro Orlando (P)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Giuseppe Fancello (G)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Giandomenico Maggiore (G)

Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.

Francesca Viberti (F)

Department of Otorhinolaryngology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Pierguido Ciabatti (P)

Department of Otorhinolaryngology, Ospedale San Donato, Arezzo, Italy.

Simone Boccuzzi (S)

Department of Otorhinolaryngology, Ospedale della Misericordia, Grosseto, Italy.

Marco Mandalà (M)

Department of Otorhinolaryngology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH